COMMUNIQUÉS West-GlobeNewswire

Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting
14/05/2018
NORCROSS, Ga., May 14, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, announced today it is proceeding with plans for a Phase 3 [...]
OrthoPediatrics Corp. Announces FDA 510(k) Clearance for its 25th Surgical System, Pediatric Nailing Platform |FEMUR
14/05/2018
WARSAW, Ind., May 14, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce U.S. Food and Drug [...]
Get the Best Bang for Your Buck with BlueChew, the First Ever Chewable Sildenafil and Tadalafil Tablet
14/05/2018
No doctor visit needed—this online, subscription-based alternative makes better sex easier than ever CHICAGO, May 14, 2018 (GLOBE NEWSWIRE) -- Things are looking up… New online subscription service BlueChew today [...]
Advantis Corp. Creates Synergy with Herb N Works
14/05/2018
NEWPORT BEACH, CA, May 14, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) announced it is finalizing a contract to acquire a percentage of Herb N Works, the premier creative branding and marketing [...]
DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21st Anniversary of Food Allergy Awareness Week
14/05/2018
Montrouge, France, May 14, 2018 DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21 st Anniversary of Food Allergy Awareness Week DBV Technologies (Euronext: DBV - ISIN: [...]
DBV Technologies s'associe à FARE pour sensibiliser la population au sujet des allergies alimentaires lors du 21e anniversaire de la Semaine nationale des allergies alimentaires
14/05/2018
Montrouge, France, le 14 mai (14h30 CEST) 2018 DBV Technologies s'associe à FARE pour sensibiliser la population au sujet des allergies alimentaires lors du 21 e anniversaire de la Semaine nationale des allergies [...]
PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility and Announces Caroline Garrett DVM from Johns Hopkins as Chief Veterinary Officer at Polarity
14/05/2018
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (NASDAQ: COOL ) announced the acquisition of a preclinical biomedical research facility in order to accelerate research and development of PolarityTE [...]
Interpace Diagnostics Announces Launch of New Thyroid Test
14/05/2018
Next Generation Mutation Panel, ThyGeNEXT®, to be Introduced at AACE BOSTON, May 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated [...]
Zosano Reaches Another Enrollment Milestone in M207-ADAM Long-term Safety Study
14/05/2018
250 subjects have enrolled in the Study The Study is set to complete enrollment on May 18th FREMONT, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”), a clinical [...]
Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum
14/05/2018
ORLANDO, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced today that it will be presenting at the 4 th Annual Immuno-Oncology: BD&L and Investment Forum on Friday, June [...]
International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
14/05/2018
CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based [...]
Dermira to Host Analyst & Investor Day on May 24, 2018
14/05/2018
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Investigators Dose First Patient in Phase 1 Study of Treos Bio’s PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
14/05/2018
SAN FRANCISCO and LONDON, May 14, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today said [...]
Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors
14/05/2018
NEW YORK and CLEVELAND, May 14, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
ALR Technologies Announces That Its ALRT Diabetes Solution Has Been Developed to an Enterprise-Scale
14/05/2018
The ALRT Diabetes Solution is an enterprise-scale product that allows healthcare systems to implement best practices for diabetes care on large populations of patients - saving lives and money. “REPRESENTS A FUNDAMENTAL [...]
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
14/05/2018
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) will host a conference call on Thursday, May 31, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Delcath’s PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology
14/05/2018
NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s PHP [...]
FDA Grants Fast Track Designation for Yamo Pharmaceutical’s L1-79 in Autism Spectrum Disorder
14/05/2018
New York, May 14, 2018 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC , a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced today that the US Food and Drug [...]
Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
14/05/2018
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Pages